Next Article in Journal
Graphene- and Graphene Oxide-Based Nanocomposite Platforms for Electrochemical Biosensing Applications
Previous Article in Journal
A Tiny Change Makes a Big Difference in the Anti-Parasitic Activities of an HDAC Inhibitor
Open AccessArticle

Protective Effect of Acteoside on Ovariectomy-Induced Bone Loss in Mice

1
Department of Pharmaceutical Analysis, School of Pharmacy, Key Laboratory of Hui Ethnic Medicine Modernization, Ministry of Education, Ningxia Medical University, 1160 Shenli Street, Yinchuan 750004, China
2
Laboratory for Functional Foods and Human Health, Center for Excellence in Post Harvest Technologies, North Caroline A & T State University, North Carolina Research Campus, 500 Laureate Way, Kannapolis, NC 28081, USA
*
Author to whom correspondence should be addressed.
These authors contributed equally to this work.
Int. J. Mol. Sci. 2019, 20(12), 2974; https://doi.org/10.3390/ijms20122974
Received: 4 May 2019 / Revised: 2 June 2019 / Accepted: 10 June 2019 / Published: 18 June 2019
(This article belongs to the Section Bioactives and Nutraceuticals)
Acteoside, an active phenylethanoid glycoside compound isolated from herbs of Cistanche, was chosen for the investigation of anti-osteoporotic effect on postmenopausal osteoporosis by using an ovariectomized (OVX) mice model. The results from in vivo experiments showed that after daily oral administration of acteoside (20, 40, and 80 mg/kg body weight/day) for 12 weeks, bone mineral density and bone biomechanical properties of OVX mice were greatly enhanced, with significant improvement in bone microarchitecture. Furthermore, biochemical parameters of bone resorption markers as well as bone formation index, including tartrate-resistant acid phosphatase, cathepsin K, deoxypyridinoline, alkaline phosphatase, and bone gla-protein, were ameliorated by acteoside treatment, whereas the body, uterus, and vagina wet weights were seemingly not impacted by acteoside administration. Acteoside significantly affected osteoclastogenesis by attenuating nuclear factor kappa B (NF-κB) and stimulating phosphoinositide 3-kinase (PI3K)/protein kinase B (AKT) signal pathways through down-regulated levels of tumor-necrosis factor receptor-associated factor 6 (TRAF6), receptor activator of nuclear factor kappa B ligand (RANKL), RANK, NFKBIA, IκB kinase β, nuclear factor of activated T-cells c2 (NFAT2), and up-regulated expressions of PI3K, AKT, and c-Fos. Accordingly, the current research validated our hypothesis that acteoside possesses potent anti-osteoporotic properties and may be a promising agent for the prevention of osteoporosis in the future. View Full-Text
Keywords: acteoside; ovariectomized mice; anti-osteoporotic; RANKL; RANK; TRAF6 acteoside; ovariectomized mice; anti-osteoporotic; RANKL; RANK; TRAF6
Show Figures

Graphical abstract

MDPI and ACS Style

Yang, L.; Zhang, B.; Liu, J.; Dong, Y.; Li, Y.; Li, N.; Zhao, X.; Snooks, H.; Hu, C.; Ma, X. Protective Effect of Acteoside on Ovariectomy-Induced Bone Loss in Mice. Int. J. Mol. Sci. 2019, 20, 2974. https://doi.org/10.3390/ijms20122974

AMA Style

Yang L, Zhang B, Liu J, Dong Y, Li Y, Li N, Zhao X, Snooks H, Hu C, Ma X. Protective Effect of Acteoside on Ovariectomy-Induced Bone Loss in Mice. International Journal of Molecular Sciences. 2019; 20(12):2974. https://doi.org/10.3390/ijms20122974

Chicago/Turabian Style

Yang, Lingling; Zhang, Bo; Liu, Jingjing; Dong, Yanhong; Li, Yanting; Li, Nan; Zhao, Xiaojun; Snooks, Hunter; Hu, Changling; Ma, Xueqin. 2019. "Protective Effect of Acteoside on Ovariectomy-Induced Bone Loss in Mice" Int. J. Mol. Sci. 20, no. 12: 2974. https://doi.org/10.3390/ijms20122974

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Search more from Scilit
 
Search
Back to TopTop